Our portfolio company Starstone has signed a strategic commercialization partnership with Ashtrom Industries, one of Israel’s most powerful construction conglomerates, to bring bio-manufactured cement to industrial scale.
This partnership is a structured roadmap that takes Starstone’s technology from lab validation all the way through to commercial deployment, at the kind of scale that actually moves the needle on how the world builds.
The construction industry faces a structural problem that no amount of incremental improvement will solve: a widening gap between cement demand and available supply, compounded by volatile SCM shortages, rising raw material and energy costs, and an infrastructure pipeline that isn’t slowing down.
The world needs more of what cement does – but the current system can’t keep up.
Starstone’s Chemistry by Design platform produces biogenic cement replacement with the consistency, purity, and throughput that construction demands, produced in purpose-built reactors, with no exotic inputs, no kilns, and a dramatically lower CO₂ footprint. A fundamentally new supply pathway, built for industrial reality.
Read more at: